BIO-UV Group S.A. (EPA:ALTUV)

Market Cap	12.04M -45.2%
Revenue (ttm)	37.31M +0.3%
Net Income	187.83K -81.2%
EPS	0.01 -83.9%
Shares Out	13.55M
PE Ratio	66.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,738
Open	0.8520
Previous Close	0.8520
Day's Range	0.8520 - 0.8900
52-Week Range	0.7740 - 1.6760
Beta	0.34
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 18, 2026

About BIO-UV Group

BIO-UV Group S.A. designs, manufactures, and markets water treatment and disinfectant systems using ultraviolet, salt electrolysis, ozone, and advanced oxidation for individuals and professionals in France, Europe, Asia, the Middle East, the United States, and internationally. The company offers disinfection equipment and systems under the triogen, AKERON, 1001 Electrodes, and BIOSEA brands; spare parts; and commissioning services. It also provides maintenance services comprising inspection and diagnosis; cleaning and replacement of parts; cali...

• Industry: Pollution & Treatment Controls
• Sector: Industrials
• Founded: 2000
• Employees: 143
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTUV

Financial Performance

In 2025, BIO-UV Group's revenue was 36.87 million, a decrease of -4.69% compared to the previous year's 38.69 million. Earnings were 836,336, an increase of 2566.80%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error